Evidence map›Paper›PMID 35328709›Full record

ArticleInternational journal of molecular sciences2022

Cleavage of LOXL1 by BMP1 and ADAMTS14 Proteases Suggests a Role for Proteolytic Processing in the Regulation of LOXL1 Function.

Tamara Rosell-García, Sergio Rivas-Muñoz, Alain Colige, Fernando Rodriguez-Pascual

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. LOXL2 in Cancer: A Two-Decade Perspective.International journal of molecular sciences · 2023
    Review
  3. Multifunctional Lysyl Oxidases.International journal of molecular sciences · 2023
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Tamara Rosell-GarcíaCentro de Biología Molecular "Severo Ochoa" Consejo Superior de Investigaciones Científicas (C.S.I.C.), Universidad Autónoma de Madrid, E-28049 Madrid, Spain.ORCID 0000-0001-8784-2769
Sergio Rivas-MuñozCentro de Biología Molecular "Severo Ochoa" Consejo Superior de Investigaciones Científicas (C.S.I.C.), Universidad Autónoma de Madrid, E-28049 Madrid, Spain.ORCID 0000-0002-6543-3603
Alain ColigeLaboratory of Connective Tissues Biology, GIGA, University of Liège, Sart Tilman, 4000 Liège, Belgium.
Fernando Rodriguez-PascualCentro de Biología Molecular "Severo Ochoa" Consejo Superior de Investigaciones Científicas (C.S.I.C.), Universidad Autónoma de Madrid, E-28049 Madrid, Spain.ORCID 0000-0002-9765-9578
Consejo Superior de Investigaciones Científicas · ESUniversity of Liège · BE

Funding

Ministerio de Ciencia e Innovacion, Spain RTI2018-095631-B-I00The Glaucoma Foundation "Unraveling the proteolytic landscape regulating LOXL1. Implications in the development of pseudoexfoliation syndrome"
6 · The paper itself

Abstract

Members of the lysyl oxidase (LOX) family catalyze the oxidative deamination of lysine and hydroxylysine residues in collagen and elastin in the initiation step of the formation of covalent cross-links, an essential process for connective tissue maturation. Proteolysis has emerged as an important level of regulation of LOX enzymes with the cleavage of the LOX isoform by metalloproteinases of the BMP1 (bone morphogenetic protein 1) and ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) families as a model example. Lysyl oxidase-like 1 (LOXL1), an isoform associated with pelvic organ prolapse and pseudoexfoliation (PEX) glaucoma, has also been reported to be proteolytically processed by these proteases. However, precise molecular information on these proteolytic events is not available. In this study, using genetic cellular models, along with proteomic analyses, we describe that LOXL1 is processed by BMP1 and ADAMTS14 and identify the processing sites in the LOXL1 protein sequence. Our data show that BMP1 cleaves LOXL1 in a unique location within the pro-peptide region, whereas ADAMTS14 processes LOXL1 in at least three different sites located within the pro-peptide and in the first residues of the catalytic domain. Taken together, these results suggest a complex regulation of LOXL1 function by BMP1- and ADAMTS14-mediated proteolysis where LOXL1 enzymes retaining variable fragments of N-terminal region may display different capabilities.

Indexed as

Exfoliation SyndromeProtein-Lysine 6-OxidaseADAMTS ProteinsAmino Acid OxidoreductasesBone Morphogenetic Protein 1HumansPeptide HydrolasesProteolysisProteomicsADAMTS14 protein, humanADAMTS ProteinsAmino Acid OxidoreductasesBMP1 protein, humanBone Morphogenetic Protein 1LOXL1 protein, humanPeptide HydrolasesProtein-Lysine 6-Oxidasea disintegrin and metalloproteinase with thrombospondin motifsbone morphogenetic protein 1elastinextracellular matrixlysyl oxidase-like 1proteolysis

Identifiers

PMID35328709
PMCPMC8951505
OpenAlexW4221056085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.